Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

计划入组 12 人 · 首次发布于 2011 年 11 月 30 日

SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

计划入组 30 人 · 首次发布于 2018 年 9 月 7 日

Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction

计划入组 22 人 · 首次发布于 2021 年 6 月 14 日

pGBI-161

HSN-431

Src-40-49-Tat

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Immuno Cure 3 Limited

CoRegen Receives FDA Clearance for First-in-Human Trial of CRG-150, a Novel Adoptive Cell Therapy Targeting SRC-3 in Multiple Solid Tumors

CoRegen's CRISPR-Edited Treg Therapy CRG-150 Advances to First-in-Human Trial in Breast and Prostate Cancers

Technology Partnership Announcement: KnectIQ and SRC UK Licensing Agreement for Defense Intelligence Platforms